PLIVA 327 (Hydralazine 25 mg)
Pill imprint PLIVA 327 has been identified as Hydralazine hydrochloride 25 mg.
Hydralazine is used in the treatment of high blood pressure; hypertensive emergency; heart failure and belongs to the drug class vasodilators. Risk cannot be ruled out during pregnancy. Hydralazine 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- PLIVA 327
- Strength:
- 25 mg
- Color:
- Orange
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Vasodilators
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals
- National Drug Code (NDC):
- 50111-0327
- Inactive Ingredients:
- lactose anhydrous
FD&C Yellow No. 6
aluminum oxide
microcrystalline cellulose
sodium starch glycolate type A potato
stearic acid
More about hydralazine
Consumer resources
- Hydralazine
- Hydralazine tablets
- Hydralazine Injection (Advanced Reading)
- Hydralazine Oral, Injection, Intravenous (Advanced Reading)
- Other brands: Apresoline
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
